Solid phase synthesis of [18F]labelled peptides for positron emission tomography

Julie Sutcliffe; Michael J. O'Doherty; Sukhvinder S. Bansal

doi:10.1016/S0960-894X(00)00179-7

Solid phase synthesis of [¹⁸F]labelled peptides for positron emission tomography

Julie Sutcliffe, Michael J. O'Doherty, Sukhvinder S. Bansal

Research output: Contribution to journal › Article

29 Scopus citations

Abstract

A strategy for the solid phase synthesis of [¹⁸F]labelled peptides has been developed. The peptides were prepared on solid support and acylated with 4-[¹⁸F]fluorobenzoic acid using HATU within 3 min and the labelled peptide was released from the solid support within 7 min. The [¹⁸F]labelled peptides were produced in good purity with a specific activity of 20-25 GBq/μmol. (C) 2000 Elsevier Science Ltd. All rights reserved.

Original language	English (US)
Pages (from-to)	1501-1503
Number of pages	3
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	10
Issue number	14
DOIs	https://doi.org/10.1016/S0960-894X(00)00179-7
State	Published - Jul 17 2000
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Organic Chemistry
Drug Discovery
Pharmaceutical Science

Access to Document

10.1016/S0960-894X(00)00179-7

Fingerprint Dive into the research topics of 'Solid phase synthesis of [<sup>18</sup>F]labelled peptides for positron emission tomography'. Together they form a unique fingerprint.

Cite this

Sutcliffe, J., O'Doherty, M. J., & Bansal, S. S. (2000). Solid phase synthesis of [¹⁸F]labelled peptides for positron emission tomography. Bioorganic and Medicinal Chemistry Letters, 10(14), 1501-1503. https://doi.org/10.1016/S0960-894X(00)00179-7

@article{da8487144660447cab6aa592584e902d,

title = "Solid phase synthesis of [18F]labelled peptides for positron emission tomography",

abstract = "A strategy for the solid phase synthesis of [18F]labelled peptides has been developed. The peptides were prepared on solid support and acylated with 4-[18F]fluorobenzoic acid using HATU within 3 min and the labelled peptide was released from the solid support within 7 min. The [18F]labelled peptides were produced in good purity with a specific activity of 20-25 GBq/μmol. (C) 2000 Elsevier Science Ltd. All rights reserved.",

author = "Julie Sutcliffe and O'Doherty, {Michael J.} and Bansal, {Sukhvinder S.}",

year = "2000",

month = jul,

day = "17",

doi = "10.1016/S0960-894X(00)00179-7",

language = "English (US)",

volume = "10",

pages = "1501--1503",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "14",

}

TY - JOUR

T1 - Solid phase synthesis of [18F]labelled peptides for positron emission tomography

AU - Sutcliffe, Julie

AU - O'Doherty, Michael J.

AU - Bansal, Sukhvinder S.

PY - 2000/7/17

Y1 - 2000/7/17

N2 - A strategy for the solid phase synthesis of [18F]labelled peptides has been developed. The peptides were prepared on solid support and acylated with 4-[18F]fluorobenzoic acid using HATU within 3 min and the labelled peptide was released from the solid support within 7 min. The [18F]labelled peptides were produced in good purity with a specific activity of 20-25 GBq/μmol. (C) 2000 Elsevier Science Ltd. All rights reserved.

AB - A strategy for the solid phase synthesis of [18F]labelled peptides has been developed. The peptides were prepared on solid support and acylated with 4-[18F]fluorobenzoic acid using HATU within 3 min and the labelled peptide was released from the solid support within 7 min. The [18F]labelled peptides were produced in good purity with a specific activity of 20-25 GBq/μmol. (C) 2000 Elsevier Science Ltd. All rights reserved.

UR - http://www.scopus.com/inward/record.url?scp=0034679765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034679765&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(00)00179-7

DO - 10.1016/S0960-894X(00)00179-7

M3 - Article

C2 - 10915036

AN - SCOPUS:0034679765

VL - 10

SP - 1501

EP - 1503

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 14

ER -